Business

MedX Health Corp Reports Third Quarter 2008 Financial Results

MISSISSAUGA, ON, Nov. 6 /CNW/ - MedX Health Corp., a global leader in drug free, non-invasive low...

articleMedx Health Corp.November 6, 20083/company/medx-health-corp/news/medx-health-corp-reports-third-quarter-2008-financial-results
MedX Health Corp Reports Third Quarter 2008 Financial Results

About this update from Medx Health Corp.

[{"type":"text","content":"\n\n\n\nMISSISSAUGA, ON, Nov. 6 /CNW/ - MedX Health Corp., a global leader in\ndrug free, non-invasive low level laser and light therapy for tissue repair\nand pain relief, today announced its results for the three months ended\nSeptember 30, 2008.\n\n\nRevenue for the three months ended September 30, 2008 was $335,567\ncompared to $308,754 for the three months ended September 30, 2007, an 8.9 per\ncent increase. These revenues are also a 29.4% increase from revenues of\n$259,235 for the second quarter of 2008.\n\n\nMedX incurred a loss from continuing operations for the quarter of\n$651,056 or $0.03 per share compared to a loss of $302,034 or $0.02 per share\nfor the same period in the prior year.\n\n\n"For the first time in many years, MedX has posted a quarter to quarter\nincrease from Q2 to Q3, 2008, as well as a quarter to quarter increase versus\nthe previous period in 2007," said Steven Guillen, chief executive officer and\npresident of MedX Health. "This is a direct result of new strategic\npartnerships, like Technology4Medicine, beginning to solidify and generate\nrevenue. We expect to see a strong finish to the year as we continue to expand\nour products and services internationally via new distribution channels,\nanticipated CE Marks in several countries, novel product technology, strategic\npartnerships and strong IP programs."\n\n\nRecent Company Achievements:\n\n - Announced strategic partnership with Technology4Medicie to become\n Medx Health's exclusive U.S. dental distributor for Oralase(TM)\n (July 15, 2008)\n - Closed non-brokered private placement of 4,800,000 common shares for\n CAD$1,200,000 during the period\n - Company profiled in the October issue of American Executive Magazine\n (October 1, 2008)\n - Received FDA Clearance for Oralase(TM) (October 6, 2008)\n\n-------------------------------------------------------------------------\nCanadian $ Q3 2008 Q3 2007\n-------------------------------------------------------------------------\nRevenue 335,567 308,754\n-------------------------------------------------------------------------\nGross Margin % 55% 70%\n-------------------------------------------------------------------------\nIncome (Loss) from continued operations (651,056) (302,034)\n-------------------------------------------------------------------------\nIncome (Loss) from di...

More updates from Medx Health Corp.